Submitted by Anonymous (not verified) on 17 February 2026 - 12:49
Human medicines European public assessment report (EPAR): Inflectra, infliximab, Date of authorisation: 10/09/2013, Revision: 34, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Inflectra, infliximab, Date of authorisation: 10/09/2013, Revision: 34, Status: Authorised